A Philadelphia Commerce Court judge has ordered reopened the deposition of a corporate vice president in a $51 million wholesale pharmaceuticals dispute after finding there is “reasonable suspicion” that counsel for the executive’s company coached the man during breaks in that original deposition.
Philadelphia Common Pleas Judge Howland W. Abramson’s recent decision in AmerisourceBergen Drug Corp. v. Curascript Inc. casts a spotlight on U.S. courts’ lack of a uniform set of rules governing conduct in depositions.
